Lanzhou Foci Pharmaceutical Stock Forum

Despite limited growth and weaker momentum, LanZhou Foci PharmaceuticalLtd's high P/E ratio indicates investors' hope for a business turnaround. However, if P/E aligns with recent growth rates, shareholders may face disappointment. Weak earnings and slower growth could risk investments and potential investors may pay an excessive premium.

The company's strong EPS growth and reasonable CEO compensation suggest good governance and alignment with shareholder interests. The company's financial performance makes it worth watching for growth investors.